journal article Aug 05, 2018

Preparation and biological evaluation of metronidazole derivatives with monoterpenes and eugenol

Chemical Biology & Drug Design Vol. 92 No. 6 pp. 1954-1962 · Wiley
View at Publisher Save 10.1111/cbdd.13366
Abstract
AbstractTwo series of metronidazole derivatives (ester derivatives and ether derivatives) were prepared reacting metronidazole and its acetic acid oxidized form with menthol, thymol, carvacrol, and eugenol. Both series of compounds were tested in vitro against two strains of Helicobacter pylori (the ATCC 26695 and P12), and one strain of Clostridium (Clostridium perfringens). Most of the prepared compounds showed biological activity against the targeted bacteria. Compound 11 was highly active against all tested bacterial strains, especially against P12 with IC50 0.0011 μM/ml. Compound 6 was highly active against C. perfringens with MIC 0.0094 nM/ml. Viability test was conducted for compound 11 to test its selectivity for normal human fetal lung fibroblasts (MRC5), and it was found to be non‐toxic with IC50 more than 50 μM/ml.
Topics

No keywords indexed for this article. Browse by subject →

References
33
[4]
Understanding the mechanisms and drivers of antimicrobial resistance

Alison H Holmes, Luke S P Moore, Arnfinn Sundsfjord et al.

The Lancet 10.1016/s0140-6736(15)00473-0
[5]
Harrison U. PLoS ONE (2017)
[12]
Metronidazole containing pyrazole derivatives potently inhibit tyrosyl‐tRNA synthetase: design, synthesis, and biological evaluation

Long‐Wang Chen, Peng‐Fei Wang, Dan‐Jie Tang et al.

Chemical Biology & Drug Design 10.1111/cbdd.12793
[14]
Mechanisms of Antibacterial Action of Three Monoterpenes

Domenico Trombetta, Francesco Castelli, Maria Grazia Sarpietro et al.

Antimicrobial Agents and Chemotherapy 10.1128/aac.49.6.2474-2478.2005
[15]
Importance of hydrogen bonding and aromaticity indices in QSAR modeling of the antioxidative capacity of selected (poly)phenolic antioxidants

Svetlana Jeremić, Slavko Radenković, Milos Filipovic et al.

Journal of Molecular Graphics and Modelling 10.1016/j.jmgm.2017.01.011
[19]
Oyedemi S. O. Afr. J. Biotechnol. (2009)
[26]
Zeb A. Med. Chem. (Los Angeles) (2012)
Related

You May Also Like

The Future of Peptide‐based Drugs

David J. Craik, David P. Fairlie · 2012

1,741 citations

Two‐ and Three‐dimensional Rings in Drugs

Matteo Aldeghi, Shipra Malhotra · 2014

334 citations

Homology modeling in drug discovery: Overview, current applications, and future perspectives

Muhammed Tilahun Muhammed, Esin Aki‐Yalcin · 2018

316 citations